November 2, 2026 · Annals of internal medicine · DOI: 10.7326/ANNALS-26-03954-JC

After 12 mo of DAPT following PCI in multivessel CAD, extended DAPT vs. aspirin alone reduced MACCE without increasing bleeding.

Listen to this summary

**Note:** The abstract provided contains only subject-category tags, so this summary is based on the title alone and may not reflect the study's full design or results. This Annals of Internal Medicine commentary by Manoj Kesarwani appears to address whether continuing dual antiplatelet therapy (DAPT) beyond 12 months after percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease, compared with aspirin alone, reduces major adverse cardiac and cerebrovascular events (MACCE). The title reports that extended DAPT lowered MACCE without a significant increase in bleeding. Because the article type and full text were not available, the study population, sample size, and effect sizes could not be confirmed.

Manoj Kesarwani

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play